HEXARELIN

270.00 AED — In stock

Hexarelin is a synthetic growth hormone-releasing peptide (GHRP) developed to strongly stimulate the pituitary gland to release endogenous growth hormone (GH). Known for its high potency, Hexarelin is studied for its role in muscle growth, fat metabolism, recovery, and anti-aging research. Unlike many GH secretagogues, Hexarelin has also been investigated for direct cardiovascular effects, including improved cardiac performance and vascular support, making it a unique peptide in both performance-focused and regenerative research settings. Key Features 🧪 cGMP manufactured in an FDA-registered facility✅ ≥98% purity confirmed by HPLC analysis📄 Batch-specific Certificates of Analysis (COAs) included💉 Sterile, lyophilized vials for research use only Human-Relevant Research Applications 🔬 Potent growth hormone release in healthy adultsThis clinical study shows that Hexarelin administration significantly increases GH secretion in healthy human volunteers in a dose-dependent manner — more than growth hormone-releasing hormone (GHRH). 🔗 https://pubmed.ncbi.nlm.nih.gov/8126144/ 💪 Dose-dependent GH release confirmed in humansA placebo-controlled dose-response study in healthy male subjects demonstrated reproducible, dose-related increases in circulating growth hormone following Hexarelin. 🔗 https://pubmed.ncbi.nlm.nih.gov/7957536/ ❤️ Cardiac performance improvement in patients with coronary artery diseaseIn people undergoing bypass surgery, acute Hexarelin administration was shown to improve cardiac performance metrics, supporting cardiovascular research interest beyond GH effects. 🔗 https://pubmed.ncbi.nlm.nih.gov/12144941/ Mechanism Summary Activates growth hormone secretagogue receptors (GHS-R) in the pituitary to stimulate GH release Engages GH/IGF-1 signaling pathways relevant to muscle growth, recovery, and fat metabolism Interacts with GHS-R expressed in cardiac tissue, contributing to direct cardiovascular effects Supports research into anabolic signaling, metabolic regulation, and cardioprotective pathways Reconstitution & Handling Guidance 1️⃣ Use sterile bacteriostatic water (0.9% benzyl alcohol)2️⃣ Add 3 ml of bacteriostatic water to reconstitute the peptide3️⃣ Gently swirl until fully dissolved (do not vortex)4️⃣ Store reconstituted peptide at 4 °C–10 °C for 2–3 months5️⃣ Unreconstituted peptide can be stored at 4 °C–10 °C until the expiration date Legal & Research Disclaimer This material is supplied exclusively for laboratory research use. It is not intended for diagnostic, therapeutic, cosmetic, human, or veterinary applications. The purchaser assumes all responsibility for compliance with applicable local, state, and federal regulations governing research compounds.

More All Products

What is HEXARELIN?

Hexarelin is a synthetic hexapeptide, a chain of six amino acids, developed in the early 1990s. It is closely related to GHRP-6. The main difference is a methyl group added to the D-tryptophan at position two, which makes it more stable.

Hexarelin acts on the ghrelin receptor (GHS-R1a), which is thought to trigger growth hormone release from the pituitary. It has also been reported to bind CD36, a receptor found in heart and blood vessel tissue. This has made it a subject of cardiovascular research.

Also known as: Examorelin, EP-23905

What are peptides?

What the research covers

Hexarelin has been studied in small human trials and animal studies. A 1994 human study found it released growth hormone after injection, and to a lesser degree after intranasal and oral use. Other studies reported that the response may lessen with repeated use. Animal studies have looked at possible effects on the heart. The human evidence is small and short-term, and it has not been through large clinical trials. Hexarelin is not approved as a medicine by the US FDA.

References

Ghigo E, Arvat E, Gianotti L, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. The Journal of Clinical Endocrinology and Metabolism. 1994.

Formats available

Vial (injectable)

Lyophilised powder in a sterile vial, reconstituted before subcutaneous injection as directed by your pharmacy.

Storage and handling

Storage: Keep unopened lyophilised vials cool and dry, away from light. After reconstitution, refrigerate at 2-8C, protect from light and do not freeze. Follow the storage instructions on your pharmacy label.

Peptide Calculator

Specification

Property	Value
Sequence	His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2
Molecular formula	C47H58N12O6
Molecular weight	approx. 887 g/mol
Peptide length	6 amino acids
Formats	Vial (injectable)

Frequently asked questions

What does the research on hexarelin show?

Small human studies show it releases growth hormone, though the effect may lessen with repeated use. Animal studies have explored effects on the heart. Large trials are lacking.

How is hexarelin different from GHRP-6?

Hexarelin is a modified form of GHRP-6 with a methyl group added for stability. Early research suggests it is more potent at releasing growth hormone, and it also binds the CD36 receptor.

Are there side effects with Hexarelin?

Side effects can occur. Your GP will review your health, medication and, where relevant, blood results before prescribing, and you should report anything unexpected.

Which formats are available and how should I store them?

Hexarelin is available as a vial (injectable). Keep unopened lyophilised vials cool and dry, away from light. After reconstitution, refrigerate at 2-8C, protect from light and do not freeze. Follow the storage instructions on your pharmacy label.

How much Hexarelin should I take?

Your dose is set by our licensed GP following a consultation, and printed on your pharmacy label.